|
|
Akshay K. Vaishnaw, Jason R. Orlinick, Jia-Li Chu, Peter H. Krammer, Moses V. Chao, Keith B. Elkon
J Clin Invest. 1999;
103(3):355
doi:10.1172/JCI5121
Abstract |
Full text
| PDF

H
eterozygous mutations of the receptor CD95 (Fas/Apo-1) are associated with defective lymphocyte apoptosis and a clinical disease characterized by lymphadenopathy, splenomegaly, and systemic autoimmunity. From our cohort of 11 families, we studied eight patients to define the mechanisms responsible for defective CD95-mediated apoptosis. Mutations in and around the death domain of CD95 had a dominant–negative effect that was explained by interference with the recruitment of the signal adapter protein, FADD, to the death domain. The intracellular domain (ICD) mutations were associated with a highly penetrant Canale-Smith syndrome (CSS) phenotype and an autosomal dominant inheritance pattern. In contrast, mutations affecting the CD95 extracellular domain (ECD) resulted in failure of extracellular expression of the mutant protein or impaired binding to CD95 ligand. They did not have a dominant–negative effect. In each of the families with an ECD mutation, only a single individual was affected. These observations were consistent with differing mechanisms of action and modes of inheritance of ICD and ECD mutations, suggesting that individuals with an ECD mutation may require additional defect(s) for expression of CSS.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(10)
| Title and authors |
Publication |
Year |
CD95-mediated cell signaling in cancer: mutations and post-translational modulations
Sébastien Tauzin, Laure Debure, Jean-François Moreau, Patrick Legembre
|
Cell. Mol. Life Sci.
|
2011 |
A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation
B. Neven, A. Magerus-Chatinet, B. Florkin, D. Gobert, O. Lambotte, L. De Somer, N. Lanzarotti, M.-C. Stolzenberg, B. Bader-Meunier, N. Aladjidi
|
Blood
|
2011 |
Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome
K. C. Dowdell, J. E. Niemela, S. Price, J. Davis, R. L. Hornung, J. B. Oliveira, J. M. Puck, E. S. Jaffe, S. Pittaluga, J. I. Cohen, T. A. Fleisher, V. K. Rao
|
Blood
|
2010 |
Underexpression and overexpression of Fas and Fas ligand: a double-edged sword
Shahid R. Randhawa, Bassem G. Chahine, Mary Lowery-Nordberg, James D. Cotelingam, Adrian M. Casillas
|
Annals of Allergy, Asthma & Immunology
|
2010 |
Residual CD95-Pathway Function in Children With Autoimmune Lymphoproliferative Syndrome Is Independent From Clinical State and Genotype of CD95 Mutation
Hans Fuchs, Carsten Posovszky, Georgia Lahr, Jutte van der Werff ten Bosch, Thomas Boehler, Klaus-Michael Debatin
|
Pediatric Research
|
2009 |
Death Receptors and Apoptosis
Emmanuel Contassot, Olivier Gaide, Lars E. French
|
Dermatologic Clinics
|
2007 |
Autoimmune Lymphoproliferative Syndrome with Somatic <i>Fas</i> Mutations
Eliska Holzelova, Cédric Vonarbourg, Marie-Claude Stolzenberg, Peter D. Arkwright, Françoise Selz, Anne-Marie Prieur, Stéphane Blanche, Jirina Bartunkova, Etienne Vilmer, Alain Fischer
|
N Engl J Med
|
2004 |
Differential recruitment of caspase 8 to cFlip confers sensitivity or resistance to Fas-mediated apoptosis in a subset of familial lymphoma patients
Caroline Bäumler, Fei Duan, Kenan Onel, Beth Rapaport, Suresh Jhanwar, Kenneth Offit, Keith B. Elkon
|
Leukemia Research
|
2003 |
Antinuclear antibodies recognize cellular autoantigens driven by apoptosis
Roxana Ramírez-Sandoval, Sergio H. Sánchez-Rodríguez, David Herrera-van Oostdam, Esperanza Avalos-Díaz, Rafael Herrera-Esparza
|
Joint Bone Spine
|
2003 |
CD8+ T cells in large granular lymphocyte leukemia are not defective in activation- and replication-related apoptosis
J.J Melenhorst, T.H Brümmendorf, M Kirby, P.M Lansdorp, A.J Barrett
|
Leukemia Research
|
2001 |
|